The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Human Leukocyte Antigen-B-Associated Transcript 3 Is Released from Tumor Cells and Engages the NKp30 Receptor on Natural Killer Cells
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Novel APC-like properties of human NK cells directly regulate T cell activation
Hanna, J., Gonen-Gross, T., Fitchett, J., Rowe, T., Daniels, M., Arnon, T. I., Gazit, R., Joseph, A., Schjetne, K. W., Steinle, A., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22787 · Cited by 162
RetractedThe Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
DAMPs, PAMPs and alarmins: all we need to know about danger
Bianchi, M. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306164 · Cited by 2,794
Lanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Lotze, M. T., & Tracey, K. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1594 · Cited by 2,487
Asea, A., Kraeft, S.-K., Kurt-Jones, E. A., Stevenson, M. A., Chen, L. B., Finberg, R. W., Koo, G. C., & Calderwood, S. K. (2000) · Nature Medicine · doi:10.1038/74697 · Cited by 1,620
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
Groh, V., Wu, J., Yee, C., & Spies, T. (2002) · Nature · doi:10.1038/nature01112 · Cited by 1,592
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
Gasser, S., Orsulic, S., Brown, E. J., & Raulet, D. H. (2005) · Nature · doi:10.1038/nature03884 · Cited by 1,308
Lipid Domain Structure of the Plasma Membrane Revealed by Patching of Membrane Components
Harder, T., Scheiffele, P., Verkade, P., & Simons, K. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.4.929 · Cited by 1,184
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
Diefenbach, A., Jensen, E. R., Jamieson, A. M., & Raulet, D. H. (2001) · Nature · doi:10.1038/35093109 · Cited by 1,083
Ferlazzo, G., Tsang, M. L., Moretta, L., Melioli, G., Steinman, R. M., & Münz, C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011149 · Cited by 994
Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells
Mandelboim, O., Lieberman, N., Lev, M., Paul, L., Arnon, T. I., Bushkin, Y., Davis, D. M., Strominger, J. L., Yewdell, J. W., & Porgador, A. (2001) · Nature · doi:10.1038/35059110 · Cited by 990
Pende, D., Parolini, S., Pessino, A., Sivori, S., Augugliaro, R., Morelli, L., Marcenaro, E., Accame, L., Malaspina, A., Biassoni, R., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1505 · Cited by 798
Gastpar, R., Gehrmann, M., Bausero, M. A., Asea, A., Gross, C., Schroeder, J. A., & Multhoff, G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3804 · Cited by 695
Unravelling natural killer cell function: triggering and inhibitory human NK receptors
Moretta, L., & Moretta, A. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600019 · Cited by 615
Cerwenka, A., Baron, J. L., & Lanier, L. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201238598 · Cited by 606
BAG-1 modulates the chaperone activity of Hsp70/Hsc70
Takayama, S. (1997) · The EMBO Journal · doi:10.1093/emboj/16.16.4887 · Cited by 514
Human natural killer cell development and biology
Farag, S. S., & Caligiuri, M. A. (2006) · Blood Reviews · doi:10.1016/j.blre.2005.10.001 · Cited by 506
Laouar, Y., Sutterwala, F. S., Gorelik, L., & Flavell, R. A. (2005) · Nature Immunology · doi:10.1038/ni1197 · Cited by 451
Vitale, M., Chiesa, M. D., Carlomagno, S., Pende, D., Aricò, M., Moretta, L., & Moretta, A. (2005) · Blood · doi:10.1182/blood-2004-10-4035 · Cited by 414
Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus
Arnon, T. I., Achdout, H., Levi, O., Markel, G., Saleh, N., Katz, G., Gazit, R., Gonen-Gross, T., Hanna, J., Nahari, E., et al. (2005) · Nature Immunology · doi:10.1038/ni1190 · Cited by 397
Dendritic cell maturation by innate lymphocytes
Münz, C., Steinman, R. M., & Fujii, S.-I. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050810 · Cited by 393
NK cells at the interface between innate and adaptive immunity
Moretta, A., Marcenaro, E., Parolini, S., Ferlazzo, G., & Moretta, L. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402170 · Cited by 387
Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia.
Robertson, M. J., Cochran, K., Cameron, C. A., Le, J. M., Tantravahi, R. V., & Ritz, J. (1996) · PubMed · Cited by 343
NKG2D function protects the host from tumor initiation
Smyth, M. J., Swann, J., Cretney, E., Zerafa, N., Yokoyama, W. M., & Hayakawa, Y. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050994 · Cited by 342
Carbone, E. (2005) · Blood · doi:10.1182/blood-2004-04-1422 · Cited by 333
Semino, C., Angelini, G., Poggi, A., & Rubartelli, A. (2005) · Blood · doi:10.1182/blood-2004-10-3906 · Cited by 328
Millar, D. G., Garza, K. M., Odermatt, B., Elford, A. R., Ono, N., Li, Z., & Ohashi, P. S. (2003) · Nature Medicine · doi:10.1038/nm962 · Cited by 286
Surface NK receptors and their ligands on tumor cells
Moretta, L., Bottino, C., Pende, D., Castriconi, R., Mingari, M. C., & Moretta, A. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.03.002 · Cited by 283
Cellular ligands of activating NK receptors
Bottino, C., Castriconi, R., Moretta, L., & Moretta, A. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.02.007 · Cited by 255
DC-NK cell cross talk as a novel CD4+ T-cell–independent pathway for antitumor CTL induction
Adam, C., King, S., Allgeier, T., Braumüller, H., Lüking, C., Mysliwietz, J., Kriegeskorte, A., Busch, D. H., Röcken, M., & Mocikat, R. (2005) · Blood · doi:10.1182/blood-2004-09-3775 · Cited by 233
MICA/NKG2D-mediated immunogene therapy of experimental gliomas.
Friese, M. A., Platten, M., Lutz, S. Z., Naumann, U., Aulwurm, S., Bischof, F., Bühring, H. ‐., DICHGANS, J., Rammensee, H., Steinle, A., et al. (2003) · PubMed · Cited by 193
Immunostimulatory functions of membrane-bound and exported heat shock protein 70
Radons, J., & Multhoff, G. (2026) · PubMed · doi:10.22029/eir.2005.1612 · Cited by 150
Banerji, J., Sands, J. F., Strominger, J. L., & Spies, T. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.6.2374 · Cited by 146
HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53
Sasaki, T., Gan, E. C., Wakeham, A. C., Kornbluth, S. A., Mak, T. W., & Okada, H. (2007) · Genes & Development · doi:10.1101/gad.1534107 · Cited by 139
Message in a bottle: Role of the 70‐kDa heat shock protein family in anti‐tumor immunity
Calderwood, S. K., Thériault, J. R., & Gong, J. (2005) · European Journal of Immunology · doi:10.1002/eji.200535002 · Cited by 137
Gehrmann, M., Marienhagen, J., Eichholtz-Wirth, H., Fritz, E., Ellwart, J. W., Jäättelä, M., Zilch, T., & Multhoff, G. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401510 · Cited by 135
Krynetski, E. Y., Krynetskaia, N. F., Bianchi, M. E., & Evans, W. E. (2003) · PubMed · Cited by 122
The human anti-CD30 antibody 5F11 shows in vitro and in vivo activity against malignant lymphoma
Borchmann, P., Treml, J., Hansen, H. P., et al. (2003) · Blood · doi:10.1182/blood-2003-02-0515 · Cited by 114
Self-citationNorth, J. M., Bakhsh, I., Marden, C. M., Pittman, H., Addison, E., Navarrete, C., Anderson, R. W., & Lowdell, M. W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.85 · Cited by 104
Natural killer cell–dendritic cell crosstalk in the initiation of immune responses
Walzer, T., Dalod, M., Vivier, É., & Zitvogel, L. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.1.s49 · Cited by 104
Reversible inhibition of Hsp70 chaperone function by Scythe and Reaper
Thress, K. S., Song, J., Morimoto, R. I., & Kornbluth, S. (2001) · The EMBO Journal · doi:10.1093/emboj/20.5.1033 · Cited by 101
The Reaper-Binding Protein Scythe Modulates Apoptosis and Proliferation during Mammalian Development
Desmots, F., Russell, H. R., Lee, Y., Boyd, K. L., & McKinnon, P. J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.23.10329-10337.2005 · Cited by 93
Self-citationRicin Triggers Apoptotic Morphological Changes through Caspase-3 Cleavage of BAT3
Wu, Y.-H., Shih, S., & Lin, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307049200 · Cited by 77
Manchen, S. T., & Hubberstey, A. V. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5701 · Cited by 49
von Strandmann, E. P., Senkel, S., & Ryffel, G. U. (2000) · Mechanisms of Development · doi:10.1016/s0925-4773(99)00269-5 · Cited by 16
Cited by
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
Stanietsky, N., Simic, H., Arapovic, J., Toporik, A., Levy, O., Novik, A., Levine, Z., Beiman, M., Dassa, L., Achdout, H., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903474106 · Cited by 3,524
NK cells for cancer immunotherapy
Shimasaki, N., Jain, A., & Campana, D. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0052-1 · Cited by 1,222
Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC
Besse, B., Charrier, M., Lapierre, V., Dansin, E., Lantz, O., Planchard, D., Le Chevalier, T., Livartoski, A., Barlesi, F., Laplanche, A., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1071008 · Cited by 749
Self-citationBrandt, C. S., Baratin, M., Yi, E. C., Kennedy, J., Gao, Z., Fox, B., Haldeman, B., Ostrander, C. D., Kaifu, T., Chabannon, C., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090681 · Cited by 706
NK cells and cancer immunosurveillance
Waldhauer, I., & Steinle, A. (2008) · Oncogene · doi:10.1038/onc.2008.267 · Cited by 682
Metadata
- Authors
- Pogge von Strandmann, E., Simhadri, V. R., von Tresckow, B., Sasse, S., Reiners, K. S., Hansen, H. P., Rothe, A., Böll, B., Simhadri, V. L., Borchmann, P., McKinnon, P. J., Hallek, M., & Engert, A.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2007-12
- Volume
- 27
- Issue
- 6
- Pages
- 965-974
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2076329388
- Cited by
- 374
- References
- 46
- FWCI
- 5.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.